Global day of service coincides with 10-year anniversary of Company’s corporate social responsibility program WHAT: Today, PerkinElmer, Inc. will host its third annual Impact Day. Employees from PerkinElmer’s sites around the world will participate in outreach activities that align with the Company’s mission of innovating for a healthier world. Over 2,000 employees in 20 countries will... Read more
Scientists at London-based gardens will leverage PerkinElmer’s infrared imaging technology for botanical science research WHAT: PerkinElmer, Inc., a global leader in innovating for a healthier world, today announced that researchers at the Royal Botantic Gardens, Kew will utilize PerkinElmer’s Spotlight™ 200 FT-IR Microscopy System to analyze samples from the Garden’s collection of 8.5 million plant... Read more
WALTHAM, Mass.–(BUSINESS WIRE)–Aug. 23, 2018– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the 16th annual Morgan Stanley Global Healthcare Conference on Friday, September 14, 2018 at 11:40 a.m. ET at the Grand Hyatt New York in New York City. Robert... Read more
21 August 2018 Combining LabChip® GX Touch Nucleic Acid Analyzer and MassARRAY® for Optimized Liquid Biopsy Workflow San Diego, CA – Agena Bioscience (Agena) announced today that they have entered into a collaboration with PerkinElmer, incorporating the LabChip® GX Touch™ nucleic acid analyzer for quality assessment and quantitation of DNA in the upfront workflow of Agena’s MassARRAY®system. The... Read more
NeoLSD™ MSMS Kit is First Commercial IVD Kit to Use Mass Spectrometry to Screen for Six LSDs in Newborn Babies from a Single Dried Blood Spot Sample WHAT: PerkinElmer, Inc., a global leader in innovating for a healthier world, today announced that it received 510(k) clearance from the FDA to commercially market its NeoLSD™ MSMS... Read more
Mailing addressesCorrespondence should be mailed to:ComputershareP.O. Box 505000Louisville, KY 40233 Overnight correspondence should be sent to:Computershare462 South 4th Street, Suite 1600Louisville, KY 40202 Shareholder website www.computershare.com/investorShareholder online inquirieswww-us.computershare.com/investor/Contact Read more
WALTHAM, Mass.–(BUSINESS WIRE)–Jul. 16, 2018– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that on Wednesday, August 1, 2018, after market close, the Company will release second quarter 2018 results. The Company will also host a conference call the same day at 5:00 p.m. EDT to discuss... Read more
International Conference on Prenatal Diagnosis and Therapy (ISPD), Booth #15, Antwerp, Belgium – July 10, 2018 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced a collaboration with Women & Infants Hospital (WIH) of Rhode Island, a Care New England hospital, to evaluate an innovative test method using the... Read more
Advanced Technologies Enable Flexible, Reliable Analysis of a Broad Range of Sample Types WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of its FL 6500™ Pulse Xenon and FL 8500™ Continuous Wave Fluorescence Spectrometers. The instruments enable industrial companies, universities, government, contract and pharmaceutical laboratories to... Read more
Testing Performed Together with EUROPattern System Can Help Accelerate Lupus Diagnosis WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that its EUROIMMUN Crithidia luciliae immunofluorescence test (CLIFT) and CLIFT sensitive assays have received FDA 510(k) clearance. CLIFT testing is critical in supporting the detection of anti-double stranded... Read more